Evidence map›Paper›PMID 30542300›Full record

ArticleFrontiers in psychiatry2018

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials.

Dongyu Kang, Zhihui Jing, Ranran Li, Gangrui Hei, Tiannan Shao, Li Li, Mengxi Sun, Ye Yang, Ying Wang, Xiaoyi Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Histamine HInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Dongyu KangDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhihui JingDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Ranran LiDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Gangrui HeiDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Tiannan ShaoDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Li LiDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Mengxi SunDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Ye YangDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Ying WangDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Xiaoyi WangDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Yujun LongDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Xiansheng HuangDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Renrong WuDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNHunan Institute of Mental Health · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antipsychotic-induced weight gain is one of the most common adverse effects of antipsychotic treatment. However, there are no well-established interventions for the weight gain yet. In this study, we pooled the data from two clinical trials, which were originally examining the efficacy of betahistine and the efficacy of metformin in treating antipsychotic-induced weight gain and insulin resistance. A total of 67 people with schizophrenia or bipolar disorder treated with antipsychotics were assigned to 36 mg day

Indexed as

antipsychotic medicationbetahistineBMIinsulin resistancemetformin

Identifiers

PMID30542300
PMCPMC6277778
OpenAlexW2902868353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.